MediciNova, Inc.
Hedge Funds Holdings
Last updated:
MediciNova, Inc.‘s stocks are currently a part of 23 hedge funds’ portfolios, which represents 5.13% of the total amount of its stocks outstanding. This makes up a total of 2.51M shares of MediciNova, Inc.. Compared to the previous quarter, the number fell by -59.48% or -3.69M shares fewer. As for the holding position changes, 17.39% (4) of current hedge fund investors increased the number of shares held, 43.48% (10) of current holders sold a part of the shares held, and 4.35% (1) closed the holdings completely. 1 hedge funds are new holders of MediciNova, Inc. stock in Q1 2023, it is 4.35% of total holders.
Hedge funds holding MediciNova (Q2 2018 – Q1 2023)
| Q2 2018 | 55 |
|---|---|
| Q3 2018 | 46 |
| Q4 2018 | 47 |
| Q1 2019 | 47 |
| Q2 2019 | 49 |
| Q3 2019 | 49 |
| Q4 2019 | 50 |
| Q1 2020 | 48 |
| Q2 2020 | 48 |
| Q3 2020 | 51 |
| Q4 2020 | 54 |
| Q1 2021 | 57 |
| Q2 2021 | 53 |
| Q3 2021 | 38 |
| Q4 2021 | 42 |
| Q1 2022 | 30 |
| Q2 2022 | 34 |
| Q3 2022 | 33 |
| Q4 2022 | 40 |
| Q1 2023 | 23 |
Hedge funds changes in MediciNova positions (Q2 2018 – Q1 2023)
| Q2 2018 | 11 | 17 | 17 | 8 | 2 |
|---|---|---|---|---|---|
| Q3 2018 | 3 | 21 | 13 | 12 | -3 |
| Q4 2018 | 6 | 19 | 15 | 5 | 2 |
| Q1 2019 | 3 | 17 | 13 | 3 | 11 |
| Q2 2019 | 7 | 21 | 12 | 3 | 6 |
| Q3 2019 | 3 | 21 | 12 | 3 | 10 |
| Q4 2019 | 8 | 22 | 10 | 7 | 3 |
| Q1 2020 | 7 | 13 | 20 | 9 | -1 |
| Q2 2020 | 9 | 19 | 13 | 9 | -2 |
| Q3 2020 | 9 | 11 | 19 | 6 | 6 |
| Q4 2020 | 12 | 20 | 13 | 9 | 0 |
| Q1 2021 | 11 | 19 | 17 | 8 | 2 |
| Q2 2021 | 17 | 13 | 19 | 21 | -17 |
| Q3 2021 | 2 | 11 | 16 | 17 | -8 |
| Q4 2021 | 9 | 15 | 10 | 4 | 4 |
| Q1 2022 | 1 | 10 | 10 | 13 | -4 |
| Q2 2022 | 4 | 3 | 15 | 0 | 12 |
| Q3 2022 | 1 | 7 | 14 | 1 | 10 |
| Q4 2022 | 9 | 10 | 12 | 3 | 6 |
| Q1 2023 | 1 | 4 | 10 | 1 | 7 |
Hedge funds changes in MediciNova stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 193,000 | 0 |
|---|---|---|
| Q3 2018 | 150,000 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 121,000 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 85,000 | 0 |
| Q3 2020 | 82,000 | 556,000 |
| Q4 2020 | 517,000 | 233,000 |
| Q1 2021 | 443,000 | 527,000 |
| Q2 2021 | 338,000 | 329,000 |
| Q3 2021 | 439,000 | 63,000 |
| Q4 2021 | 238,000 | 0 |
| Q1 2022 | 184,000 | 0 |
| Q2 2022 | 29,000 | 0 |
| Q3 2022 | 5,000 | 0 |
| Q4 2022 | 33,005 | 0 |
| Q1 2023 | 15,000 | 0 |